A
new research report from U.S.-based Transparency Market Research
examines the global antibacterial drugs market and arrives at studied
conclusions about the market’s expected trajectory during the
forecast period 2013-2019. The report states that the global market
for antibacterial drugs was worth US$43.55 billion in 2012. Helped by
factors such as the growing prevalence of bacterial diseases around
the world and growth in geriatric population with weakened immune
systems due to age, the market is expected to rise at a 0.3% CAGR
from 2013 to 2019, to eventually reach a total value of US$45.09
billion.The report, titled ‘Antibacterial Drugs Market - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -
2019’, draws on extensive primary and secondary research to
formulate conclusions, employing trusted analytical tools such as
Porter’s five forces analysis, market attractiveness analysis, and
SWOT analysis.
Browse
the full Antibacterial Drugs Market Report at
http://www.transparencymarketresearch.com/antibacterial-drugs-market.html
Porter’s
five forces analysis reveals the tussle between the established
players and new entrants, threat to branded products from
substitutes, and the relative power of buyers and suppliers. Use of
market attractiveness analysis helps develop the crucial part of the
report: recommendations for market players regarding the feasibility
of investment in the market in the forecast period. SWOT analysis
helps expand upon the competitive landscape of the market, to provide
a comparative overview of the major players operating in the global
antibacterial drugs market.“Despite the strong factors working in
its favor, the global antibacterial drugs market is restrained by a
number of equally influential issues. This is the reason why the CAGR
of the market is expected to remain negligible in the forecast
period,” states a TMR analyst.
Browse
the full Press Release :
Major
restraints acting on the antibacterial drugs market are the
proliferation of generic drugs, aided by ongoing patent expiration of
several blockbuster drugs, and rise in multi-drug resistant strains
of pathogenic bacteria. The latter is exacerbated by the weak
pipeline of novel antibacterial drugs at present, and can be resolved
by increased funding on constantly evolving product development.The
antibacterial drugs market is segmented into seven segments by drug
class, of which B-Lactams emerged as the market leader in 2012,
holding a whopping 57% share in the market. Quinolones, which were
the second largest class of antibacterial drugs in the global market
the same year, are expected to regress in the forecast period owing
to heightened risk of complications due to the usage of this
quinolones and impending patent expirations.Of pipeline antibacterial
drugs, the report profiles the data regarding delafloxacin,
surotomycin, ceftolozane/tazobactam, tedizolid, dalbavancin, CAZ AVI,
oritavancin, and others. Forecasts for the development of these
products till 2019 are presented in the report.
Among
the major antibacterial drugs market players, the report examines the
business operations, product catalog, and financial standing of
companies such as Bayer AG, AstraZeneca, Eli Lilly, Johnson and
Johnson, Merck, Sanofi, GSK, Sanofi, Pfizer, and Novartis. A
comprehensive overview of the market’s competitive landscape is
presented in the report to aid market stakeholders assess market
conditions and modify their market strategies accordingly.
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1567
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
